CareDx to to Participate in Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
CareDx, a leader in precision medicine, has announced its participation in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CareDx, a leader in precision medicine, has announced its participation in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference. This event will take place on February 18, 2021, at 3:30 PM EST, where the company's management will present insights about their high-value healthcare solutions for transplant patients.
Investors can tune in to the live and archived webcast through CareDx's investor relations site. The company is dedicated to developing testing services and digital healthcare solutions for transplant patients.
Details
News Market Reaction – CDNA
The recorded move for CDNA in the trading session of this news was -0.95%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that the Company will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference.
CareDx’s management is also scheduled to present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Thursday, February 18, 2021 at 3:30 PM EST. Interested parties can access the live and archived webcast at investors.caredxinc.com.
About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
CONTACTS:
Investor Relations
Greg Chodaczek
347-620-7010
investor@caredx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.